Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: Glycosylated Ferritin in Macrophagic Activation Syndromes

View source ↗

Summary

This clinical trial update describes a study evaluating glycosylated ferritin in macrophage activation syndrome associated with adult-onset Still's disease and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brugmann University Hospital | Conditions: Still's Disease, Adult-Onset, Sepsis | Status: RECRUITING